Emeryville, CA, United States of America

Abran Q Costales

USPTO Granted Patents = 11 (Patent Applications = 4)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 10.0

ph-index = 6

Forward Citations = 73(Granted Patents)

Location History:

Emeryville, CA (US) (2010 - 2014)
El Cerrito, CA (US) (2008 - 2020)

Company Filing History:

Novartis Vaccines & Diagnostics, Gmbh

Chevron Oronite Company LLC

patents

where one patent can have more than one assignee

Years Active: 2008-2020

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10815446 - Dispersants, method of making, and using same (2020-10-27),

2. 10112931 - 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH (2018-10-30),

3. 9688672 - 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH (2017-06-27),

4. 9434719 - 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH (2016-09-06),

5. 8957068 - 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH (2015-02-17),

6. 8859548 - Compounds and compositions as protein kinase inhibitors (2014-10-14),

7. 8563553 - Compounds and compositions as protein kinase inhibitors (2013-10-22),

8. 8415382 - Substituted benzazoles and methods of their use as inhibitors of RAF Kinase (2013-04-09),

9. 8242260 - Compounds and compositions as protein kinase inhibitors (2012-08-14),

10. 7671059 - 2-amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-ones (2010-03-02),

11. 7423150 - Substituted benzazoles and methods of their use as inhibitors of Raf kinase (2008-09-09),

Title: The Innovative Path of Inventor Abran Q Costales.

Introduction:

Inventor Abran Q Costales, based in Emeryville, CA (US), is a prolific inventor with an impressive portfolio of 11 patents. His groundbreaking work spans across diverse fields, showcasing his expertise and ingenuity in developing novel solutions.

Latest Patents:

Among Costales' latest patents is the development of dispersants and their method of production and application. These dispersants are specifically formulated for use in lubricating oils, demonstrating Costales' commitment to enhancing industrial processes with innovative solutions. Another notable patent of his involves 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH proteins, unlocking new possibilities in the treatment of diseases like cancer.

Career Highlights:

Costales has made significant contributions to the research and development departments of esteemed companies such as Novartis AG and Novartis Vaccines & Diagnostics, Gmbh. His work showcases a dedication to pushing the boundaries of innovation in the pharmaceutical and healthcare industries.

Collaborations:

Throughout his career, Costales has collaborated closely with talented individuals in the field. Notable coworkers include Cynthia Shafer and Daniel J Poon, who have contributed to the successful development and implementation of Costales' innovative ideas.

Conclusion:

In conclusion, Abran Q Costales stands as a visionary inventor whose indelible mark on the field of innovation is evident through his prolific patent portfolio and groundbreaking research. His collaborations with top-tier companies and talented colleagues have solidified his reputation as a trailblazer in the industry, consistently pushing the boundaries of what is possible through innovation.

This text is generated by artificial intelligence and may not be accurate.